miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells

In this study, we investigated the roles of miR-132 in tumor growth of osteosarcoma. We found that overexpression of miR-132 significantly suppressed in vitro cell proliferation and in vivo tumor growth. In addition, miR-132 overexpression induced G1/S cell cycle arrest of osteosarcoma cells. Further study showed that miR-132 could interact with the 3′-untranslated region of cyclin E1 (CCNE1) gene and repress its expression. Re-expression of CCNE1 (without the 3′UTR) could partially abrogate the miR-132-induced cell proliferation inhibition. Of significance, contrary to CCNE1, expression level of miR-132 was significantly lower in osteosarcoma tissues than in the adjacent normal tissues. Taken together, these results indicate that miR-132 functions as a tumor suppressor in osteosarcoma and that its suppressive effects are mediated chiefly by repressing CCNE1 expression.

[1]  E. Kleinerman,et al.  miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. , 2012, Cancer research.

[2]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.

[3]  E. Chan,et al.  MicroRNA in TLR signaling and endotoxin tolerance , 2011, Cellular and Molecular Immunology.

[4]  Kang Han,et al.  miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma. , 2012, Oncology reports.

[5]  Yusuke Yamamoto,et al.  MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  Zhenfeng Duan,et al.  MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration , 2011, Molecular Cancer Therapeutics.

[7]  G. Hannon,et al.  Chromosomal mapping of the genes for the human cell cycle proteins cyclin C (CCNC), cyclin E (CCNE), p21 (CDKN1) and KAP (CDKN3). , 1995, Cytogenetics and cell genetics.

[8]  Xian-gui Hu,et al.  Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. , 2011, Carcinogenesis.

[9]  Jintang Xia,et al.  miR‐124 inhibits cell proliferation in gastric cancer through down‐regulation of SPHK1 , 2012, The Journal of pathology.

[10]  H. Yokozaki,et al.  Frequent Amplification of the Cyclin E Gene in Human Gastric Carcinomas , 1995, Japanese journal of cancer research : Gann.

[11]  Shuai Li,et al.  MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. , 2013, Pathology, research and practice.

[12]  Michael G. Garelick,et al.  Neuronal activity rapidly induces transcription of the CREB‐regulated microRNA‐132, in vivo , 2009, Hippocampus.

[13]  A. Davis,et al.  Prognostic factors in osteosarcoma: a critical review. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Blay,et al.  Micro‐RNA profiles in osteosarcoma as a predictive tool for ifosfamide response , 2011, International journal of cancer.

[15]  G. Ottaviani,et al.  The epidemiology of osteosarcoma. , 2009, Cancer treatment and research.

[16]  V. Ambros microRNAs Tiny Regulators with Great Potential , 2001, Cell.

[17]  Yandan Yao,et al.  MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor , 2009, Clinical Cancer Research.

[18]  Jie Tang,et al.  Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma , 2013, Molecular and Cellular Biochemistry.

[19]  Jae Kwan Lee,et al.  Detection of MicroRNA as Novel Biomarkers of Epithelial Ovarian Cancer From the Serum of Ovarian Cancer Patient , 2013, International Journal of Gynecologic Cancer.

[20]  A. Levine,et al.  DNA methylation silences miR-132 in prostate cancer , 2013, Oncogene.

[21]  S. Alahari,et al.  miRNA control of tumor cell invasion and metastasis , 2010, International journal of cancer.

[22]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[23]  Zhu Jianwei,et al.  MicroRNA 181a improves proliferation and invasion, suppresses apoptosis of osteosarcoma cell , 2013, Tumor Biology.

[24]  David M. Thomas,et al.  Cyclin E1 is amplified and overexpressed in osteosarcoma. , 2011, The Journal of molecular diagnostics : JMD.